Min Jiang is the Director of AI at Eli Lilly and Company, where they have been leading efforts since 2023. Previously, they served as an NLP Scientist at Pieces Technologies, enhancing healthcare analytics through data science from 2017 to 2021, and held various research roles at Eli Lilly and Company from 2018 to 2021. Min's career also includes contributions as a Scientific Programmer at the School of Biomedical Informatics at the University of Texas at Houston and as a Health System Software Engineer at Vanderbilt University Medical Center, where they were part of a team that achieved recognition in the 2010 I2B2 NLP Challenge. They hold a PhD in Health Informatics from The University of Texas Health Science Center at Houston, complemented by master's degrees from Zhejiang University and the University of Florida.
This person is not in any teams
This person is not in any offices